MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms

O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

Meeting: 2022 International Congress

Abstract Number: 874

Keywords: Anxiety, Depression, Psychosis

Category: Rating Scales

Objective: Explore the relationship between patient self-reported assessment of positive symptoms, depression, and anxiety in PwPD.

Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by cognitive, psychiatric, autonomic dysfunction beyond the traditional motor impact. Psychiatric symptoms may affect up to 50% of people with PD (PwPD) and might adversely impact the capacity for independent functioning with activities of daily living. Accurate identification of the degree of psychiatric/behavioral symptoms may enhance the provider’s ability to assess patient quality of life (QoL) and intervene with behavioral or pharmacotherapy for management of these symptoms. Clinicians’ awareness of these non-motor issues in PwPD might be insufficient.

Method: Retrospective review of data collected through routine care of PwPD that were evaluated by incorporating and combining multidimensional patient reported outcomes (PROs): Hospital Anxiety and Depression Scale (HADS), Scale for the Assessment of Positive Symptoms (SAPS-PD), Questionnaire on the Psychosocial Consequences of Parkinson’s Disease (SCOPA-PS).

Results: 124 PwPD, 60% male, average age 73+/- 11. Significant relationships were identified by regression analysis (p<0.05) for the following: HADS-Anxiety and SAPS (r2 = 0.13), HADS-Depression and SAPS (r2 = 0.17), SCOPA-PS vs SAPS-PD (r2= 0.20), SCOPA-PS vs HADS-Anxiety (r2=0.28), SCOPA-PS vs HADS-Depression (r2=0.47).

Conclusion: Psychiatric issues reported in PwPD are complex and intertwined.  Psychosocial impact of PD can be influenced by multiple factors but appears to be very influenced by the level of depression.  However, anxiety and other positive psychiatric symptoms (SAPS-PD) also play significant roles impacting the psychosocial consequences for PwPD.  Enhanced clinician awareness of and addressing these issues comprehensively in routine care of PwPD are also important to improve QoL.

scopa vs hads A

scopa vs saps

SCOPA vs HADS

SAPS-PD vs HADS

To cite this abstract in AMA style:

O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt. Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/parkinsons-disease-and-psychosocial-impact-anxiety-depression-and-positive-symptoms/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-and-psychosocial-impact-anxiety-depression-and-positive-symptoms/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley